TY - JOUR
KW - Administration, Inhalation
KW - Adrenergic beta-2 Receptor Agonists/adverse effects
KW - *Asthma/diagnosis/drug therapy
KW - Bronchodilator Agents/adverse effects
KW - *Cardiovascular Diseases/chemically induced/diagnosis/epidemiology
KW - Case-Control Studies
KW - Humans
KW - *Pulmonary Disease, Chronic Obstructive/complications/diagnosis/drug therapy
KW - Asthma
KW - chronic obstructive pulmonary disease
KW - nested case–control
AU - J. Amegadzie
AU - J. Gamble
AU - J. Farrell
AU - Z. Gao
AD - Faculty of Medicine, Memorial University of Newfoundland, St. John's, Newfoundland, Canada.
Faculty of Science, School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.
AN - 35645559
BT - Int J Chron Obstruct Pulmon Dis
C2 - PMC9130098
DO - 10.2147/copd.s358927
DP - NLM
ET - 2022/06/02
LA - eng
N1 - 1178-2005
Amegadzie, Joseph Emil
Orcid: 0000-0002-0459-7241
Gamble, John-Michael
Orcid: 0000-0001-6891-8721
Farrell, Jamie
Orcid: 0000-0002-1719-8477
Gao, Zhiwei
Orcid: 0000-0002-5313-4884
Journal Article
Int J Chron Obstruct Pulmon Dis. 2022 May 20;17:1205-1217. doi: 10.2147/COPD.S358927. eCollection 2022.
PY - 2022
SN - 1176-9106 (Print)
1176-9106
SP - 1205
EP - 1217
T2 - Int J Chron Obstruct Pulmon Dis
TI - Association between Inhaled β(2)-agonists Initiation and Risk of Major Adverse Cardiovascular Events: A Population-based Nested Case-Control Study
VL - 17
ER -